Skip to Main Content

Author Details

Silke Stertz
Institute of Medical Virology, University of Zurich
2004
53
26
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36537693Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus Inactivation.Environ Sci Technol2023
37594288Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MS.mSphere2023
37819131The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.J Virol2023
35081340Phosphoproteomic profiling of influenza virus entry reveals infection-triggered filopodia induction counteracted by dynamic cortactin phosphorylation.Cell Rep2022
35766385Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.ACS Infect Dis2022
35535160Unraveling virus-induced cellular signaling cascades by label-free quantitative phosphoproteomics.STAR Protoc2022
35867415Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.Microbiol Spectr2022
36037391Expiratory aerosol pH is determined by indoor room trace gases and particle size.Proc Natl Acad Sci U S A2022
35320721Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.Cell Rep2022
34083772An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.Nat Nanotechnol2021
33882122IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.J Exp Med2021
33760807SARS-CoV-2 variants reveal features critical for replication in primary human cells.PLoS Biol2021
33757684Interferon system deficiencies exacerbating severe pandemic virus infections.Trends Microbiol2021
33838498Entry of influenza A virus into host cells - recent progress and remaining challenges.Curr Opin Virol2021
32152316TIGIT limits immune pathology during viral infections.Nat Commun2020
31964943Antiviral potential of 3'-sialyllactose- and 6'-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses.Sci Rep2020
31776280Breaking the Convention: Sialoglycan Variants, Coreceptors, and Alternative Receptors for Influenza A Virus Entry.J Virol2020
32913009Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.mBio2020
32848003Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.mSphere2020
30787439MHC class II proteins mediate cross-species entry of bat influenza viruses.Nature2019
31363119Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation.Nat Commun2019
28643205Role of Host Genes in Influenza Virus Replication.Curr Top Microbiol Immunol2018
30206219Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target.Nat Commun2018
28369159Context-based retrieval of functional modules in protein-protein interaction networks.Brief Bioinform2018
29493494A novel mutation in the neuraminidase gene of the 2009 pandemic H1N1 influenza A virus confers multidrug resistance.J Gen Virol2018
28819179Identification of Polo-like kinases as potential novel drug targets for influenza A virus.Sci Rep2017
27449792Late stages of the influenza A virus replication cycle-a tight interplay between virus and host.J Gen Virol2016
27613601Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.BMC Genomics2016
25320322Swine interferon-inducible transmembrane proteins potently inhibit influenza A virus replication.J Virol2015
26575457Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry.J Vis Exp2015
26651948Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.Cell Host Microbe2015
26112615Recent strategies and progress in identifying host factors involved in virus replication.Curr Opin Microbiol2015
26060270Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.mBio2015
25984567A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein.ACS Infect Dis2015
25657216Correction for lanz et Al., Swine interferon-inducible transmembrane proteins potently inhibit influenza a virus replication.J Virol2015
24225499Entry of influenza A virus: host factors and antiviral targets.J Gen Virol2014
25031340Prolidase is required for early trafficking events during influenza A virus entry.J Virol2014
23487453Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.J Virol2013
23926347Emergence of a C-terminal seven-amino-acid elongation of NS1 in around 1950 conferred a minor growth advantage to former seasonal influenza A viruses.J Virol2013
23720581Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.Sci Transl Med2013
21276872Uncovering the global host cell requirements for influenza virus replication via RNAi screening.Microbes Infect2011
20027183Human host factors required for influenza virus replication.Nature2010
20739532Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.J Virol2010
20975689Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.Nat Commun2010
20126449Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.PLoS Pathog2010
18199636Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.J Virol2008
17210170The intracellular sites of early replication and budding of SARS-coronavirus.Virology2007
17970694The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.J Interferon Cytokine Res2007
18062906The Mx GTPase family of interferon-induced antiviral proteins.Microbes Infect2007
17307214Interferon-induced inhibition of parainfluenza virus type 5; the roles of MxA, PKR and oligo A synthetase/RNase L.Virology2007
  • 1 - 50 of 53

Recommended Authors

Hanover Medical School
Career Start Year 2017
Number of shared co-authors 7
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 19
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 8
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 7
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 8
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 29
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 34
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 15
Rutgers University
Career Start Year 2007
Number of shared co-authors 3
University of California san francisco
Career Start Year 2006
Number of shared co-authors 8
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 8
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 1
Harbin Veterinary Research Institute
Career Start Year 2005
Number of shared co-authors 3
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 8
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 4
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 7
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 18
Washington State University
Career Start Year 2000
Number of shared co-authors 0
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2000
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 29
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 30
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 5
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 25
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 6
University of Washington
Career Start Year 1978
Number of shared co-authors 6
Institute of Virology, Philipps University
Career Start Year 1965
Number of shared co-authors 10

Collaborators

Institute of Medical Virology, University of Zurich
Co-authored papers 18
Icahn School of Medicine at Mount Sinai
Co-authored papers 12
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers 10
Roche Pharma Research and Early Development
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
The Scripps Research Institute
Co-authored papers 5
Institute of Medical Virology, University of Zurichgrid.0.3
Co-authored papers 4
University of Iowa
Co-authored papers 4
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 4
Paul-Ehrlich-Institut
Co-authored papers 3
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
Institute of Medical Virology, University of Zurich
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Saint Louis University School of Medicine
Co-authored papers 2
University of California riverside
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Genomics Institute of the Novartis Research Foundation
Co-authored papers 2
University of California irvine
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 1
NYU Grossman School of Medicine
Co-authored papers 1
Merck & Co., Inc.
Co-authored papers 1
Center for Comparative Medicine and Surgery, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
University of California san francisco
Co-authored papers 1